Literature DB >> 27732336

Vertebral Volumetric Bone Density and Strength Are Impaired in Women With Low-Weight and Atypical Anorexia Nervosa.

Katherine N Bachmann1, Melanie Schorr1, Alexander G Bruno2,3, Miriam A Bredella4, Elizabeth A Lawson1, Corey M Gill5, Vibha Singhal1,6, Erinne Meenaghan7, Anu V Gerweck7, Meghan Slattery7, Kamryn T Eddy8, Seda Ebrahimi9, Stuart L Koman10, James M Greenblatt10, Robert J Keane10, Thomas Weigel11, Madhusmita Misra1,6, Mary L Bouxsein2,3, Anne Klibanski1, Karen K Miller1.   

Abstract

Context: Areal bone mineral density (BMD) is lower, particularly at the spine, in low-weight women with anorexia nervosa (AN). However, little is known about vertebral integral volumetric BMD (Int.vBMD) or vertebral strength across the AN weight spectrum, including "atypical" AN [body mass index (BMI) ≥18.5 kg/m2]. Objective: To investigate Int.vBMD and vertebral strength, and their determinants, across the AN weight spectrum. Design: Cross-sectional observational study. Setting: Clinical research center. Participants: 153 women (age 18 to 45): 64 with low-weight AN (BMI <18.5 kg/m2; 58% amenorrheic), 44 with atypical AN (18.5≤BMI<23 kg/m2; 30% amenorrheic), 45 eumenorrheic controls (19.2≤BMI<25 kg/m2). Measures: Int.vBMD and cross-sectional area (CSA) by quantitative computed tomography of L4; estimated vertebral strength (derived from Int.vBMD and CSA).
Results: Int.vBMD and estimated vertebral strength were lowest in low-weight AN, intermediate in atypical AN, and highest in controls. CSA did not differ between groups; thus, vertebral strength (calculated using Int.vBMD and CSA) was driven by Int.vBMD. In AN, Int.vBMD and vertebral strength were associated positively with current BMI and nadir lifetime BMI (independent of current BMI). Int.vBMD and vertebral strength were lower in AN with current amenorrhea and longer lifetime amenorrhea duration. Among amenorrheic AN, Int.vBMD and vertebral strength were associated positively with testosterone. Conclusions: Int.vBMD and estimated vertebral strength (driven by Int.vBMD) are impaired across the AN weight spectrum and are associated with low BMI and endocrine dysfunction, both current and previous. Women with atypical AN experience diminished vertebral strength, partially due to prior low-weight and/or amenorrhea. Lack of current low-weight or amenorrhea in atypical AN does not preclude compromise of vertebral strength.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Year:  2017        PMID: 27732336      PMCID: PMC5413107          DOI: 10.1210/jc.2016-2099

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography.

Authors:  R Paul Crawford; Christopher E Cann; Tony M Keaveny
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

2.  Testosterone administration in women with anorexia nervosa.

Authors:  K K Miller; K A Grieco; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

3.  Association between lean mass, fat mass, and bone mineral density: a meta-analysis.

Authors:  Lan T Ho-Pham; Uyen D T Nguyen; Tuan V Nguyen
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

4.  Vertebral size, bone density, and strength in men and women matched for age and areal spine BMD.

Authors:  Alexander G Bruno; Kerry E Broe; Xiaochun Zhang; Elizabeth J Samelson; Ching-An Meng; Rajaram Manoharan; John D'Agostino; L Adrienne Cupples; Douglas P Kiel; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

5.  The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.

Authors:  Serra Ucer; Srividhya Iyer; Shoshana M Bartell; Marta Martin-Millan; Li Han; Ha-Neui Kim; Robert S Weinstein; Robert L Jilka; Charles A O'Brien; Maria Almeida; Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

6.  Long-term fracture risk among women with anorexia nervosa: a population-based cohort study.

Authors:  A R Lucas; L J Melton; C S Crowson; W M O'Fallon
Journal:  Mayo Clin Proc       Date:  1999-10       Impact factor: 7.616

Review 7.  Androgens and bone.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Steroids       Date:  2008-10-17       Impact factor: 2.668

8.  Preservation of neuroendocrine control of reproductive function despite severe undernutrition.

Authors:  K K Miller; S Grinspoon; S Gleysteen; K A Grieco; J Ciampa; J Breu; D B Herzog; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

Review 9.  Determinants of GH resistance in malnutrition.

Authors:  Pouneh K Fazeli; Anne Klibanski
Journal:  J Endocrinol       Date:  2014-01-27       Impact factor: 4.286

10.  Treatment of anorexia nervosa is associated with increases in bone mineral density, and recovery is a biphasic process involving both nutrition and return of menses.

Authors:  Jennifer Dominguez; Linnea Goodman; Surupa Sen Gupta; Laurel Mayer; Sarah Fischer Etu; B Timothy Walsh; Jack Wang; Richard Pierson; Michelle P Warren
Journal:  Am J Clin Nutr       Date:  2007-07       Impact factor: 7.045

View more
  7 in total

Review 1.  Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.

Authors:  Monica Grover; Laura K Bachrach
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

2.  Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder.

Authors:  Melanie Schorr; Anne Drabkin; Micol S Rothman; Erinne Meenaghan; Gillian T Lashen; Margherita Mascolo; Ashlie Watters; Tara M Holmes; Kate Santoso; Elaine W Yu; Madhusmita Misra; Kamryn T Eddy; Anne Klibanski; Philip Mehler; Karen K Miller
Journal:  Clin Endocrinol (Oxf)       Date:  2019-04-01       Impact factor: 3.478

Review 3.  Eating disorders and bone metabolism in women.

Authors:  Lauren Robinson; Nadia Micali; Madhusmita Misra
Journal:  Curr Opin Pediatr       Date:  2017-08       Impact factor: 2.856

4.  Anorexia Nervosa and Bone.

Authors:  Melanie Schorr; Anne Klibanski
Journal:  Curr Opin Endocr Metab Res       Date:  2018-01-31

5.  Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.

Authors:  Laura E Dichtel; Elizabeth A Lawson; Melanie Schorr; Erinne Meenaghan; Margaret Lederfine Paskal; Kamryn T Eddy; Graziano Pinna; Marianela Nelson; Ann M Rasmusson; Anne Klibanski; Karen K Miller
Journal:  Neuropsychopharmacology       Date:  2017-11-01       Impact factor: 7.853

6.  Management of eating disorders for people with higher weight: clinical practice guideline.

Authors:  Angelique F Ralph; Leah Brennan; Sue Byrne; Belinda Caldwell; Jo Farmer; Laura M Hart; Gabriella A Heruc; Sarah Maguire; Milan K Piya; Julia Quin; Sarah K Trobe; Andrew Wallis; A J Williams-Tchen; Phillipa Hay
Journal:  J Eat Disord       Date:  2022-08-18

7.  Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial.

Authors:  Melanie Schorr Haines; Allison Kimball; Erinne Meenaghan; Katherine N Bachmann; Kate Santoso; Kamryn T Eddy; Vibha Singhal; Seda Ebrahimi; Esther Dechant; Thomas Weigel; Lori Ciotti; Robert J Keane; Suzanne Gleysteen; Diane Mickley; Miriam A Bredella; Can Ozan Tan; Rajiv Gupta; Madhusmita Misra; David Schoenfeld; Anne Klibanski; Karen K Miller
Journal:  J Bone Miner Res       Date:  2021-09-02       Impact factor: 6.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.